Topic: biomedical research
Another scientist who previously worked for GSK has admitted conspiring to steal trade secrets and pass them on to a Chinese rival.
Engineers at LumaCyte and Thermo Fisher demonstrated rapid analysis of viral vaccines using a combination of optics and microfluidics.
Researchers showed AI can predict therapy responses using a radiomic biomarker, by analyzing CT images for prior immune system infiltration of tumors.
A former GSK scientist has pleaded guilty to attempting to steal confidential research and funnel it to conspirators in China.
Novo Nordisk has signed another deal intended to keep it at the top of the tree when it comes to developing new diabetes and obesity drugs.
Ironwood will walk away from its deal for AstraZeneca’s billion-dollar gout treatment lesinurad, following poor market performance.
HiFiBiO Therapeutics has signed a deal with Japanese Big Pharma and biotech friend Takeda to work on antibody therapies.
An AI startup raised $1 million to develop “machine reading” programs to digest and distill published biomedical literature and research.
Amgen’s R&D head, Sean Harper, is stepping down to pursue new opportunities in startups and early-stage companies.
Gilead’s senior director of clinical research, Adrian Ray, has moved to Nimbus Therapeutics to become its senior vice president of discovery biology.